Chargement en cours...
Telaprevir/boceprevir era: From bench to bed and back
Hepatitis C virus (HCV) infects approximately 200 million people worldwide. Interferon-based therapies have dominated over the past two decades. However, the overall response rates remain suboptimal. Thanks to the tremendous effort from both academia and industry, two serine protease inhibitors tela...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Co., Limited
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3501765/ https://ncbi.nlm.nih.gov/pubmed/23180937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i43.6183 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|